Please login to your online account to display your discounted pricing

Phospho-ERK 1/2 (T202/Y204) Mouse anti-Human, Mouse, Clone: MILAN8R, eBioscience™

Mouse Monoclonal Antibody

$201.55 - $433.55

Specifications

Antigen Phospho-ERK 1/2 (T202/Y204)
Clone MILAN8R
Host Species Mouse
Gene Alias MAPK, ERK, p42/p44
Species Reactivity Human, Mouse
View More Specs

 Disclaimers

For Research Use Only.

Products
Catalog Number Mfr. No. Quantity Price Quantity    

501122761

 
affymetrix
14910980
25μg Each for $201.55

501128621

 
affymetrix
14-9109-82
100μg Each for $433.55
Description & Specifications

Specifications

Antigen Phospho-ERK 1/2 (T202/Y204)
Clone MILAN8R
Host Species Mouse
Gene Alias MAPK, ERK, p42/p44
Species Reactivity Human, Mouse
Applications Flow Cytometry (Intracellular Staining)
Applications Immunocytochemistry
Applications Immunohistochemistry
Applications Immunohistochemistry (Formalin/Paraffin)
Applications Western Blotting
Regulatory Status RUO
Conjugate Unlabeled
Format Purified
Storage Requirements Store at 2-8°C.
Primary or Secondary Primary
Monoclonal or Polyclonal Monoclonal
Formulation aqueous buffer, 0.09% sodium azide, may contain carrier protein/stabilizer
Concentration 0.5mg/mL

This MILAN8R monoclonal antibody recognizes human and mouse extracellular signal-regulated kinases 1 and 2 (also known as ERK1/2, p44/p42, or MAPK3/1) when phosphorylated on T202/Y204. ERK1/2 belong to a family of conserved serine/threonine protein kinases known as mitogen-activated protein kinases (MAPKs) that are involved in many cellular programs such as proliferation, differentiation, motility, and survival. ERK1/2 signaling is activated in response to numerous extracellular stimuli including mitogens, growth factors, and cytokines. The primary activators of ERK1/2 are MEK1 and MEK2 which act by phosphorylating the activation loop residues T202/Y204 and T185/Y187 in ERK1 and ERK2, respectively. Several downstream targets of ERK1/2 have been identified, including p90RSK and the transcription factor Elk-1. ERK1/2 are negatively regulated by MAPK phosphatases, known as DUSPs or MKPs, as well as by chemical inhibitors of MEK including U0126 and PD98059. Disruption of the ERK pathway is common in many types of cancer.